Hoese & CO LLP Medtronic PLC Transaction History

Hoese & CO LLP

$130 Million
Q3 2025

A detailed history of Hoese & CO LLP transactions in Medtronic PLC stock. As of the latest transaction made, Hoese & CO LLP holds 2,384 shares of MDT stock, worth $216,228. This represents 0.18% of its overall portfolio holdings.

Number of Shares

2,384

Previous 2,384 -0.0%

Holding current value

$216,228

Previous $207,000 9.66%

% of portfolio

0.18%

Previous 0.17%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 29, 2025	BUY	$80.68 - $88.86 $112,387 - $123,781	1,393 Added 140.57%	2,384 $207,000
Q4 2024 Jan 16, 2025	SELL	$79.61 - $92.24 $1,592 - $1,844	-20 Reduced 1.98%	991 $79,000
Q2 2024 Jul 03, 2024	BUY	$78.71 - $87.02 $1,574 - $1,740	20 Added 2.02%	1,011 $79,000
Q2 2023 Jul 12, 2023	SELL	$79.47 - $91.38 $635,760 - $731,040	-8,000 Reduced 88.98%	991 $87,000
Q4 2022 Jan 10, 2023	SELL	$76.18 - $87.74 $229,987 - $264,887	-3,019 Reduced 25.14%	8,991 $710,000
Q3 2022 Oct 07, 2022	SELL	$80.75 - $95.31 $104,975 - $123,903	-1,300 Reduced 9.77%	12,010 $970,000
Q2 2022 Jul 12, 2022	BUY	$87.4 - $113.09 $1.06 Million - $1.37 Million	12,150 Added 1047.41%	13,310 $1.2 Million
Q1 2022 Apr 21, 2022	SELL	$100.58 - $112.38 $1.24 Million - $1.38 Million	-12,300 Reduced 91.38%	1,160 $129,000
Q4 2021 Jan 18, 2022	BUY	$99.53 - $127.75 $25,678 - $32,959	258 Added 1.95%	13,460 $1.39 Million
Q3 2021 Oct 20, 2021	SELL	$122.75 - $135.17 $18,412 - $20,275	-150 Reduced 1.12%	13,202 $1.66 Million
Q2 2021 Jul 13, 2021	BUY	$118.19 - $131.5 $14,064 - $15,648	119 Added 0.9%	13,352 $1.66 Million
Q4 2020 Feb 16, 2021	BUY	$100.57 - $117.14 $1.33 Million - $1.55 Million	13,233 New	13,233 $1.55 Million

Others Institutions Holding MDT

# of Institutions

2,488

Shares Held

1.07B

Call Options Held

10.9M

Put Options Held

9.18M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $121B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hoese & CO LLP, based on Form 13F filings with the SEC.

News

Stay updated on Hoese & CO LLP with notifications on news.

Account